University of Northern Colorado Presenting PharmaCyte Biotech's...

University of Northern Colorado Presenting PharmaCyte Biotech's...


PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , today announced that its research partner, the University of Northern Colorado , has submitted abstracts for the presentation of two scientific papers at the 253rd American Chemical Society National Meeting & Exposition in San Francisco, California, April 2-6, 2017. The ACS National Meeting provides chemistry professionals a forum to meet, share ideas and advance scientific and technical knowledge.



from Biotech News